Brought to you by:
FDA grants approval for IDE study on Advance Evero 18 everolimus-coated balloon catheter
The Food and Drug Administration (FDA) has granted approval for Cook Medical to initiate an investigational device exemption (IDE) study on the Advance Evero 18 everolimus-coated percutaneous transluminal angioplasty (PTA) balloon catheter, the company reported today. The clinical study…
FDA deems Envveno’s VenoValve ‘not-approvable’
The Food and Drug Administration (FDA) has issued a letter to Envveno Medical stating that its VenoValve technology is “not-approvable,” a company press release published today reports. The letter was issued in response to Envveno’s premarket approval (PMA) application for…
VAM 2026 chairs discuss pathways to podium, poster presentations
Whether you’re a seasoned vascular surgeon or a first-time attendee, Society for Vascular Surgery (SVS) Program Committee Chair Jason Lee, MD, and Postgraduate Education Committee (PGEC) Chair Claudie Sheahan, MD, want you to know there’s a place—and a pathway—for everyone…
Not all carotid procedures are equal after patients suffer a postoperative stroke
Comparative analysis looks at stroke-related disability and mortality after three modes of carotid revascularization. Strokes after transfemoral carotid artery stenting (TFCAS) were “the most disabling and lethal” when compared with transcarotid artery revascularization (TCAR) and carotid endarterectomy (CEA) in a…
Vascular Verification Program opens doors for early engagement, quality improvement
You don’t have to be too far down the path to get started. That’s the message William Shutze, MD, chair of the Society for Vascular Surgery (SVS)-American College of Surgeons (ACS) Vascular Verification Program (VVP), wants vascular specialists across the…
Aquedeon Medical receives FDA approval to expand clinical trial of Duett vascular graft system
The Food and Drug Administration (FDA) has approved the expansion of Aquedeon Medical’s investigational device exemption (IDE) clinical trial evaluating the Duett vascular graft system, a company press release reveals. Duett is a novel device designed to facilitate open surgical repair…
In wake of President Trump’s chronic venous insufficiency diagnosis, SVS steps up to educate public
News that U.S. President Donald J. Trump has a vascular condition may have simultaneously revealed that a substantial seven-figure vascular surgery branding campaign was starting to yield tangible results, and provided a singular opportunity to platform the specialty as the…
Regional vascular societies gear up for fall annual meetings
The glut of early fall regional vascular society annual meetings is just around the corner, with no fewer than five slated for the month of September. Several have recently made announcements about standout events taking place at their conferences, with…
SVS Executive Board votes against creating free-standing Vascular Surgery Board
After two years of careful deliberation, the Society for Vascular Surgery (SVS) Executive Board (EB) has voted against pursuing the creation of a free-standing Vascular Surgery Board (VSB), opting instead to maintain the current federated board structure under the American…
Analysis of BEST-CLI, PREVENT III reveals significant improvement in vein bypass outcomes over 20-year period
A post-hoc comparison of the BEST-CLI and PREVENT III multicenter, prospective, randomized controlled trials (RCTs) aimed at evaluating outcomes of vein bypass in chronic limb threatening ischemia (CLTI) patients over the past two decades found that they had “significantly improved”…